The Discounted Cash Flow (DCF) valuation of Pharma Research Products Co Ltd (214450.KQ) is 365,506.18 KRW. With the latest stock price at 452,000.00 KRW, the upside of Pharma Research Products Co Ltd based on DCF is -19.1%.
Based on the latest price of 452,000.00 KRW and our DCF valuation, Pharma Research Products Co Ltd (214450.KQ) is a sell. selling 214450.KQ stocks now will result in a potential gain of 19.1%.
Range | Selected | |
WACC / Discount Rate | 5.8% - 8.5% | 7.1% |
Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
Fair Price | 223,338.84 - 1,028,272.65 | 365,506.18 |
Upside | -50.6% - 127.5% | -19.1% |